Redness and swelling on your vulva is never a welcome sight—but for a 46-year-old unnamed woman, blistering on her genitals led to a diagnosis of a rare autoimmune disorder. The new case study, ...
DSG3-CAART is designed to selectively target the cause of mucosal pemphigus vulgaris. The Food and Drug Administration (FDA) has granted Fast Track designation to DSG3-CAART (desmoglein 3 chimeric ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Significantly ...
Justdial on MSN
Pemphigus: Types, Symptoms, Causes, Diagnosis and Treatment
Learn about pemphigus, an autoimmune skin disease. Explore its symptoms, causes, diagnosis methods, treatment options, and the long-term management tips ...
Please provide your email address to receive an email when new articles are posted on . Research shows nearly 20% of patients with pemphigus experience relapse. An additional dose of rituximab in ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The conventional treatment mainstays for pemphigus are problematic during the COVID-19 pandemic, ...
Learn about autoimmune blistering disorders, their types, symptoms, causes, diagnosis, treatment options, complications, and ...
Rituximab was found to be superior to mycophenolate mofetil (MMF) in adult patients with severe pemphigus vulgaris, according to new phase 3 trial data. Rituximab was found to be superior to ...
A study of patients with pemphigus who were in remission after a rituximab cycle found that administering an additional infusion at month 6, when guided by relapse predictors, significantly improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback